Compare Meiragtx Holdings (328) vs. Competitors

0 Followers

Comparison Results

328

Meiragtx Holdings

€12.00

€933.15M

13.95

33.80%

5 Buy

1 Hold

0 Sell

Strong Buy

Taysha Gene Therapies

$6.02

$1.46B

-10.39

-0.68%

8 Buy

0 Hold

0 Sell

Strong Buy

―

4D Molecular Therapeutics

$14.91

$713.76M

-4.62

49.52%

9 Buy

1 Hold

0 Sell

Strong Buy

―

Erasca

$19.49

$5.15B

-15.05

513.73%

6 Buy

2 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

328 vs ERAS

xxxxxxxxxxxxx

Performance Comparison

DE:328

Meiragtx Holdings

9.50

2.40

33.80%

TSHA

Taysha Gene Therapies

4.39

-0.33

-6.99%

OPT

―

FDMT

4D Molecular Therapeutics

12.56

4.24

50.96%

TERN

―

ERAS

Erasca

14.30

11.82

476.61%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >